Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook
The biologics contract development and manufacturing organization (cdmo) market in Canada is expected to reach a projected revenue of US$ 3,677.5 million by 2033. A compound annual growth rate of 8.3% is expected of Canada biologics contract development and manufacturing organization (cdmo) market from 2026 to 2033.
Revenue, 2025 (US$M)
$1,932.1
Estimate, 2026 (US$M)
$2,105.7
Forecast, 2033 (US$M)
$3,677.5
CAGR, 2026 - 2033
8.3%
Global Market
Related Markets
Canada biologics contract development and manufacturing organization (cdmo) market highlights
- The Canada biologics contract development and manufacturing organization (cdmo) market generated a revenue of USD 1,932.1 million in 2025 and is expected to reach USD 3,677.5 million by 2033.
- The Canada market is expected to grow at a CAGR of 8.3% from 2026 to 2033.
- In terms of segment, monoclonal antibodies (mabs) was the largest revenue generating product in 2025.
- Nucleic Acid Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Biologics contract development and manufacturing organization (cdmo) market data book summary
| Market revenue in 2025 | USD 1,932.1 million |
| Market revenue in 2033 | USD 3,677.5 million |
| Growth rate | 8.3% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies (mabs) |
| Fastest growing segment | Nucleic Acid Therapeutics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies (mAbs), Recombinant Proteins & Enzymes, Vaccines, Cell & Gene Therapies, Nucleic Acid Therapeutics, Other Product |
| Key market players worldwide | Lonza, Catalent Pharma Solutions, Samsung BioLogics, WuXi Biologics., Thermo Fisher Scientific Inc, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim, Rentschler Biopharma SE, AGC Biologics, Charles River Laboratories International Inc., Siegfried Holding AG, Sandoz, GenScript, Vetter Pharma, IDT Biologika |
Other key industry trends
- In terms of revenue, Canada accounted for 4.0% of the global biologics contract development and manufacturing organization (cdmo) market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. biologics contract development and manufacturing organization (cdmo) market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 3,677.5 million by 2033.
No credit card required*
Publish Date: Apr 24, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biologics Contract Development And Manufacturing Organization (CDMO) Market Scope
Biologics Contract Development And Manufacturing Organization (CDMO) Market segmentation & scope
Biologics Contract Development And Manufacturing Organization (CDMO) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Siegfried Holding AG | View profile | 4,180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | www.siegfried.ch |
| Rentschler Biopharma SE | View profile | 501-1000 | Laupheim, Baden-Wurttemberg, Germany, Europe | www.rentschler-biopharma.com |
| AGC Biologics | View profile | 1001-5000 | Bothell, Washington, United States, North America | www.agcbio.com/ |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | www.samsungbiologics.com/ |
| IDT Biologika | View profile | 1001-5000 | Dessau, Sachsen-Anhalt, Germany, Europe | idt-biologika.de/ |
| Catalent Pharma Solutions | View profile | 5001-10000 | Somerset, New Jersey, United States, North America | www.catalent.com |
| Charles River Laboratories International Inc. | View profile | - | - | - |
| GenScript | View profile | - | - | - |
Canada Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibodies (Mabs) was the largest segment with a revenue share of 45.41% in 2025.
Horizon Databook has segmented the Canada biologics contract development and manufacturing organization (cdmo) market based on monoclonal antibodies (mabs), recombinant proteins & enzymes, vaccines, cell & gene therapies, nucleic acid therapeutics, other product covering the revenue growth of each sub-segment from 2021 to 2033.
- Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market Product Outlook (Revenue, USD Million , 2021-2033)
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins & Enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic Acid Therapeutics
- Other Product
- Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market Service Outlook (Revenue, USD Million , 2021-2033)
- Packaging and Labelling
- Regulatory Affairs
- Logistics & Storage
- Other Service
- Contract Development
- Contract Manufacturing
- Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market Source Outlook (Revenue, USD Million , 2021-2033)
- Mammalian
- Microbial
- Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Commerical
- Clinical
- Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market Therapeutic Area Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Neurological Diseases
- Other Therapeutic Area
- Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- Other End Use
Reasons to subscribe to Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook databook
- Our clientele includes a mix of Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Biologics Contract Development And Manufacturing Organization (CDMO) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Canada Biologics Contract Development And Manufacturing Organization (Cdmo) Market, 2021-2033 (US$M)
Canada biologics contract development and manufacturing organization (cdmo) market statistics, by product, 2021-2033 (US$M)
